Nephrol Dial Transplant (2001) 16: 2072-2074
© 2001 European Renal Association-European Dialysis and Transplant Association
Technical Notes
Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis
Service de Néphrologie, CHU Dupuytren, Avenue Martin Luther King, Limoges, France
Abstract
Background. The indwelling venous catheter such as Dual-Cath® or Twin-Cath® is widely used in haemodialysis. Although the manufacturer recommends filling the catheter lumen with heparin after the dialysis session to prevent clotting, little is known about the systemic effects of such a procedure.
Methods. Twenty haemodialysis patients with Dual-Cath® were studied. Dialysis anticoagulation was achieved by injecting a bolus of dalteparin. The patient/control ratio of activated partial thromboplastin time (aPTT) was determined at the end of the session immediately before and 10 min after locking with 2 ml of undiluted heparin (10 000 U/catheter). We also determined the catheter volume for each patient and measured aPTT immediately before and 10 min after heparin locking with this patient-specific volume. Catheter patency was followed over a 2-week period.
Results. The aPTT values determined at the end of two consecutive dialysis sessions were nearly normal, respectively 1.29 (±0.17) and 1.33 (±0.22), whereas all patients had uncoagulable blood (aPTT >3.75) 10 min after locking with 2 ml of heparin. When catheter volumes were individually calculated, they were found to be substantially lower than 2.0 ml (1.21±0.12 for the arterial branch and 1.27±0.13 for the venous branch). aPTT was only 2.42±0.73 10 min after locking with the estimated volumes except in one patient (aPTT >3.75). No catheter clotting was observed despite these smaller locking volumes.
Conclusions. A risk of inducing serious bleeding does indeed exist with Dual-Cath® heparin locking, especially in postoperative patients. This risk can be reduced by measuring catheter length at the time of placement in order to ensure an appropriate lock volume. Sodium citrate, polygeline, or urokinase are possible alternatives to heparin.
Keywords: indwelling venous haemodialysis catheters; heparin locking
Notes
Correspondence and offprint requests to: Hüseyin Karaaslan, Service de Néphrologie, CHU Dupuytren, Avenue Martin Luther King, F-87000 Limoges, France. Email: karagom{at}free.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Steczko, S. R. Ash, D. E. Nivens, L. Brewer, and R. K. Winger Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens) Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1937 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sauer, J. Steczko, and S. R. Ash Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions J. Antimicrob. Chemother., May 1, 2009; 63(5): 937 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Markota, D. Markota, and M. Tomic Measuring of the heparin leakage into the circulation from central venous catheters--an in vivo study Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1550 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sungur, E. Eryuksel, S. Yavas, A. Bihorac, A. J. Layon, and L. Caruso Exit of catheter lock solutions from double lumen acute haemodialysis catheters an in vitro study Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3533 - 3537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Allon Current Management of Vascular Access Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 786 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Lok, D. Appleton, C. Bhola, B. Khoo, and R. M. A. Richardson Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters Nephrol. Dial. Transplant., February 1, 2007; 22(2): 477 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Grudzinski, P. Quinan, S. Kwok, and A. Pierratos Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin Nephrol. Dial. Transplant., February 1, 2007; 22(2): 471 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Flanigan Melagatran anticoagulation during haemodialysis--'Primum non nocere' Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1789 - 1790. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Weijmer, M. A. van den Dorpel, P. J.G. Van de Ven, P. M. ter Wee, J. A.C.A. van Geelen, J. O. Groeneveld, B. C. van Jaarsveld, M. G. Koopmans, C. Y. le Poole, A. M. Schrander-Van der Meer, et al. Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2769 - 2777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Agharazii, I. Plamondon, M. Lebel, P. Douville, and S. Desmeules Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1238 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Weijmer, Y. J. Debets-Ossenkopp, F. J. van de Vondervoort, and P. M. ter Wee Superior antimicrobial activity of trisodium citrate over heparin for catheter locking Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2189 - 2195. [Abstract] [Full Text] [PDF]
|
|